Zyversa Therapeutics Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zyversa Therapeutics Inc's ROI in the first quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Zyversa Therapeutics Inc 's return on investment (ROI) in its first quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Investment Change TTM	-	-	-67.16 %	-37.59 %	-45.23 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-14	-12	-12	7	9
Return On Investment (TTM)	-	-	-	-99.94 %	-99.07 %
ZVSA's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-59.09 %	-7.07 %	-7.96 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-24	-25	-26	-8	-9

ZVSA Company Profile >> Back to ZVSA Roi Comparisons >> See Annual ZVSA Return On Investment

Return On Investment ZVSA's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Zyversa Therapeutics Inc's I. Quarter Investments	$ -14 Millions	ZVSA's Balance sheet
Zyversa Therapeutics Inc's I. Quarter Income	$ -2 Millions	Quarterly ZVSA's Income Statement
ZVSA's Income by Division		See ZVSA's Income by Division

ZVSA Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2021) 2021
Total Investments in Millions	-12	9	12	125	77
Y / Y Investment Growth	-	-21.41 %	-90.44 %	62.2 %	-
Net Income in Millions	-25	-9	-14	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-100.48 %	-117.85 %	-0.19 %	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZVSA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZVSA's Competitors
Subscribers only: Roi for Zyversa Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ZVSA's Customers

Other Ratios
ZVSA's Roa	ZVSA's Inventory Turnover Ratio	ZVSA's Growth Rates	ZVSA's Dividend Statistics
	ZVSA's Profitability Ratios	ZVSA's Asset Turnover Ratio	ZVSA's Dividend Growth
ZVSA's Roe	ZVSA's Valuation Ratios	ZVSA's Financial Strength Ratios	ZVSA's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector	ROI
Glucotrack Inc	537.70 %
Sanuwave Health Inc	313.81 %
Elutia Inc	232.45 %
Silexion Therapeutics Corp	206.92 %
Kyntra Bio Inc	155.01 %
Rigel Pharmaceuticals Inc	132.72 %
Interpace Biosciences Inc	130.15 %
Oncotelic Therapeutics Inc	129.74 %
Coherus Oncology inc	128.80 %
Petros Pharmaceuticals inc	124.23 %
Arbutus Biopharma Corp	119.86 %
Quince Therapeutics Inc	114.14 %
Capforce Inc	102.27 %
Qhslab Inc	83.28 %
Advanced Biomed Inc.	81.85 %
Entera Bio Ltd	78.23 %
Pulmatrix Inc	77.85 %
Exelixis Inc	77.71 %
Ironwood Pharmaceuticals inc	72.86 %
Lensar Inc	71.13 %
Fortress Biotech Inc	70.93 %
Earth Science Tech Inc	68.75 %

Date modified: 2026-09-08T15:11:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.